Human <i>CTSZ</i> variants are associated with TB severity, and CTSZ is present at the host-pathogen interface within human pulmonary <i>Mtb</i> granulomas. حسب Rachel K. Meade (22216529)

الموضوعات:

Growth of certain cancer cell lines requires IRE1 but not its enzymatic activity. حسب Iratxe Zuazo-Gaztelu (21071939)

الموضوعات:

IRE1 silencing downregulates cell cycle genes and engages TP53 and specific CDK inhibitors. حسب Iratxe Zuazo-Gaztelu (21071939)

الموضوعات:

IRE1 depletion induces cell cycle arrest independently of apoptosis. حسب Iratxe Zuazo-Gaztelu (21071939)

الموضوعات:

Data from: <b>Selection and genetic variation in plasticity drive age-related decreases in among-individual behavioural correlations</b> حسب Chang Seok Han (21814121)

"…Our findings indicate that the magnitudes of both the positive among-individual and genetic correlations were maintained across nymph and young adult stages, but significantly decreased with age during adulthood. This decrease was due to both selection and genetic variation in age-related behavioural plasticity. …"

Figure 3 from TGFβ Inhibition during Radiotherapy Enhances Immune Cell Infiltration and Decreases Metastases in Ewing Sarcoma حسب Jessica D. Daley (22128489)

Data Sheet 1_Dihydroartemisinin decreases pre-existing neutralizing antibodies against adeno-associated virus in challenged mice.pdf حسب Jingjing Fang (124938)

Changes in the distribution of average sleep duration. حسب Hea Ree Park (10769827)

الموضوعات:

Changes in symptoms of insomnia and excessive daytime sleepiness during the COVID-19 pandemic by age. حسب Hea Ree Park (10769827)

الموضوعات:

Changes in sleep patterns before versus during the COVID-19 pandemic by age. حسب Hea Ree Park (10769827)

الموضوعات:

Sociodemographic characteristics. حسب Hea Ree Park (10769827)

الموضوعات:

Regression analysis of sleep habits and sleep-related symptoms associated with pandemic status. حسب Hea Ree Park (10769827)

الموضوعات:

Study flow chart. حسب Hea Ree Park (10769827)

الموضوعات:

Change in Demoralization Scale (DSII) by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

I Optimal design for optimization of Axitinib loaded Spanlastics. حسب Randa Mohammed Zaki (21637175)

الموضوعات:

ANOVA for I optimal design of Axitinib loaded Spanlastics. حسب Randa Mohammed Zaki (21637175)

الموضوعات:

The kinetic release data of the optimized formula compared to drug suspension. حسب Randa Mohammed Zaki (21637175)

الموضوعات:

Composition of different formulations with their responses in I optimal design for optimization of Axitinib loaded Spanlastics. حسب Randa Mohammed Zaki (21637175)

الموضوعات:

The composition and validation of the optimized formula with its predicted responses according to I Optimal Design. حسب Randa Mohammed Zaki (21637175)

الموضوعات:

Schematic representation of the experimental design. حسب Halime Tozak Yıldız (21238185)

الموضوعات: